| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 13.14% | Raymond James | $305 → $304 | Maintains | Outperform |
| 07/24/2023 | 13.51% | Piper Sandler | $290 → $305 | Maintains | Overweight |
| 07/24/2023 | 13.51% | Raymond James | → $305 | Upgrades | Market Perform → Outperform |
| 05/30/2023 | 9.79% | Morgan Stanley | → $295 | Assumes | → Overweight |
| 05/08/2023 | -3.24% | Citigroup | $250 → $260 | Maintains | Neutral |
| 05/08/2023 | 5.69% | Barclays | $282 → $284 | Maintains | Overweight |
| 05/05/2023 | 7.93% | Piper Sandler | $260 → $290 | Upgrades | Neutral → Overweight |
| 04/12/2023 | 13.14% | Keybanc | → $304 | Upgrades | Sector Weight → Overweight |
| 04/04/2023 | 2.34% | Evercore ISI Group | $280 → $275 | Maintains | Outperform |
| 02/03/2023 | 9.79% | Morgan Stanley | $290 → $295 | Maintains | Overweight |
| 02/03/2023 | -3.24% | Piper Sandler | $245 → $260 | Maintains | Neutral |
| 01/06/2023 | 7.93% | Morgan Stanley | $275 → $290 | Maintains | Overweight |
| 01/03/2023 | 7.93% | B of A Securities | $250 → $290 | Upgrades | Neutral → Buy |
| 12/12/2022 | -6.96% | Citigroup | $220 → $250 | Upgrades | Sell → Neutral |
| 11/23/2022 | 1.23% | Goldman Sachs | $319 → $272 | Maintains | Buy |
| 11/11/2022 | -8.82% | Piper Sandler | $255 → $245 | Maintains | Neutral |
| 10/11/2022 | 2.34% | Morgan Stanley | $272 → $275 | Maintains | Overweight |
| 08/16/2022 | 18.72% | Goldman Sachs | $278 → $319 | Maintains | Buy |
| 07/18/2022 | 4.21% | Stifel | $290 → $280 | Maintains | Buy |
| 07/15/2022 | 1.23% | Morgan Stanley | $282 → $272 | Maintains | Overweight |
| 07/11/2022 | -12.54% | Citigroup | $265 → $235 | Downgrades | Neutral → Sell |
| 06/24/2022 | 2.34% | Wells Fargo | → $275 | Upgrades | Equal-Weight → Overweight |
| 05/06/2022 | 4.95% | Morgan Stanley | $295 → $282 | Maintains | Overweight |
| 05/06/2022 | -5.1% | Piper Sandler | $265 → $255 | Maintains | Neutral |
| 04/11/2022 | 9.79% | Morgan Stanley | $293 → $295 | Maintains | Overweight |
| 04/01/2022 | 6.07% | Wells Fargo | $275 → $285 | Maintains | Equal-Weight |
| 03/28/2022 | 9.04% | Morgan Stanley | $310 → $293 | Maintains | Overweight |
| 02/04/2022 | 15.37% | Morgan Stanley | $300 → $310 | Maintains | Overweight |
| 02/04/2022 | 2.34% | SVB Leerink | $270 → $275 | Maintains | Market Perform |
| 01/07/2022 | 11.65% | Morgan Stanley | $285 → $300 | Maintains | Overweight |
| 12/08/2021 | -3.24% | Piper Sandler | $285 → $260 | Downgrades | Overweight → Neutral |
| 08/06/2021 | -1.38% | JP Morgan | → $265 | Downgrades | Overweight → Neutral |
| 08/06/2021 | -6.96% | SVB Leerink | $260 → $250 | Maintains | Market Perform |
| 05/25/2021 | 0.48% | Barclays | → $270 | Initiates Coverage On | → Equal-Weight |
| 05/07/2021 | -3.24% | SVB Leerink | $270 → $260 | Maintains | Market Perform |
| 02/05/2021 | 4.21% | Citigroup | $273 → $280 | Maintains | Neutral |
| 01/29/2021 | 4.95% | Raymond James | $270 → $282 | Maintains | Outperform |
| 12/15/2020 | 10.53% | Morgan Stanley | → $297 | Upgrades | Equal-Weight → Overweight |
| 12/15/2020 | -1.38% | Wells Fargo | → $265 | Downgrades | Overweight → Equal-Weight |
| 11/06/2020 | -2.49% | Morgan Stanley | $270 → $262 | Maintains | Equal-Weight |
| 10/12/2020 | 0.48% | Raymond James | $285 → $270 | Maintains | Outperform |
| 08/27/2020 | 0.48% | Morgan Stanley | $285 → $270 | Maintains | Equal-Weight |
| 08/10/2020 | 4.21% | UBS | $265 → $280 | Maintains | Neutral |
| 08/10/2020 | 6.07% | Morgan Stanley | $248 → $285 | Maintains | Equal-Weight |
| 08/07/2020 | 6.07% | Raymond James | $265 → $285 | Maintains | Outperform |
| 07/15/2020 | 3.09% | SVB Leerink | $262 → $277 | Maintains | Market Perform |
| 07/09/2020 | 11.65% | Barclays | → $300 | Upgrades | Equal-Weight → Overweight |
| 06/25/2020 | -7.7% | Morgan Stanley | $255 → $248 | Maintains | Equal-Weight |
| 06/25/2020 | -1.38% | Raymond James | $290 → $265 | Maintains | Outperform |
| 06/01/2020 | 3.46% | Goldman Sachs | → $278 | Initiates Coverage On | → Buy |
| 05/14/2020 | 10.16% | Piper Sandler | $286 → $296 | Maintains | Overweight |
| 05/08/2020 | -2.49% | SVB Leerink | $245 → $262 | Reiterates | → Market Perform |
| 05/08/2020 | 4.21% | Stifel | $265 → $280 | Maintains | Buy |
| 05/08/2020 | -1.38% | UBS | $260 → $265 | Maintains | Neutral |
| 05/08/2020 | 3.46% | CFRA | $285 → $278 | Maintains | Hold |
| 05/08/2020 | 7.93% | Raymond James | $283 → $290 | Maintains | Outperform |
| 05/08/2020 | -3.24% | Citigroup | $234 → $260 | Maintains | Neutral |
| 04/08/2020 | -8.82% | SVB Leerink | $269 → $245 | Maintains | Market Perform |
| 04/08/2020 | 0.48% | Wells Fargo | $279 → $270 | Maintains | Overweight |
| 04/01/2020 | -1.38% | Stifel | $280 → $265 | Maintains | Buy |
| 03/27/2020 | -12.91% | Citigroup | $260 → $234 | Maintains | Neutral |
| 03/27/2020 | -5.1% | Morgan Stanley | $271 → $255 | Maintains | Equal-Weight |
| 03/05/2020 | -3.24% | Citigroup | → $260 | Initiates Coverage On | → Neutral |
| 02/07/2020 | 0.86% | Morgan Stanley | $287 → $271 | Maintains | Equal-Weight |
| 02/07/2020 | 3.83% | Wells Fargo | $285 → $279 | Maintains | Overweight |
| 02/07/2020 | 5.32% | Raymond James | $288 → $283 | Downgrades | Strong Buy → Outperform |
| 02/07/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 02/07/2020 | 2.34% | Cowen & Co. | $306 → $275 | Downgrades | Outperform → Market Perform |
| 02/06/2020 | 6.07% | CFRA | $304 → $285 | Downgrades | Buy → Hold |
| 01/22/2020 | 10.9% | Keybanc | $284 → $298 | Maintains | Overweight |
| 01/08/2020 | 2.34% | Barclays | → $275 | Downgrades | Overweight → Equal-Weight |
| 12/20/2019 | 11.65% | JP Morgan | $285 → $300 | Maintains | Overweight |
| 12/17/2019 | 6.81% | Morgan Stanley | $261 → $287 | Maintains | Equal-Weight |
| 12/16/2019 | 9.79% | Stifel | $275 → $295 | Maintains | Buy |
| 11/13/2019 | -4.73% | Keybanc | $262 → $256 | Maintains | Overweight |
| 11/06/2019 | 6.07% | Wells Fargo | $290 → $285 | Maintains | Outperform |
| 09/06/2019 | 7.93% | Wells Fargo | $270 → $290 | Maintains | Outperform |
| 07/16/2019 | -2.87% | Morgan Stanley | $250 → $261 | Maintains | Equal-Weight |
| 06/28/2019 | 7.18% | Raymond James | $265 → $288 | Maintains | Strong Buy |
| 05/13/2019 | -1% | Barclays | → $266 | Upgrades | Equal-Weight → Overweight |
| 05/10/2019 | 0.48% | BMO Capital | $272 → $270 | Maintains | Market Perform |
| 05/10/2019 | -6.96% | Morgan Stanley | $255 → $250 | Maintains | Equal-Weight |
| 05/10/2019 | -6.96% | UBS | $265 → $250 | Maintains | Neutral |
| 05/10/2019 | -2.49% | Keybanc | $273 → $262 | Maintains | Overweight |
| 04/15/2019 | -1% | Barclays | $260 → $266 | Maintains | Equal-Weight |
| 03/19/2019 | 4.21% | Raymond James | $290 → $280 | Maintains | Strong Buy |
| 01/02/2019 | -10.68% | Morgan Stanley | $265 → $240 | Maintains | Equal-Weight |
| 01/02/2019 | -4.73% | Citigroup | $279 → $256 | Maintains | Buy |
| 12/07/2018 | 4.21% | Deutsche Bank | → $280 | Initiates Coverage On | → Buy |
| 11/28/2018 | -3.24% | UBS | → $260 | Initiates Coverage On | → Neutral |
| 11/13/2018 | 3.83% | Citigroup | $289 → $279 | Maintains | Buy |
| 11/08/2018 | 1.6% | Keybanc | $264 → $273 | Maintains | Overweight |
| 10/16/2018 | 3.46% | Barclays | → $278 | Initiates Coverage On | → Equal-Weight |
| 10/04/2018 | 4.21% | Morgan Stanley | $250 → $280 | Maintains | Equal-Weight |
| 08/08/2018 | 5.32% | Citigroup | $274 → $283 | Maintains | Buy |
What is the target price for Becton, Dickinson (BDX)?
The latest price target for Becton, Dickinson (NYSE: BDX) was reported by Raymond James on August 4, 2023. The analyst firm set a price target for $304.00 expecting BDX to rise to within 12 months (a possible 13.14% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Becton, Dickinson (BDX)?
The latest analyst rating for Becton, Dickinson (NYSE: BDX) was provided by Raymond James, and Becton, Dickinson maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Becton, Dickinson (BDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Becton, Dickinson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Becton, Dickinson was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Becton, Dickinson (BDX) correct?
While ratings are subjective and will change, the latest Becton, Dickinson (BDX) rating was a maintained with a price target of $305.00 to $304.00. The current price Becton, Dickinson (BDX) is trading at is $268.70, which is out of the analyst's predicted range.